IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-031-69118-8_6.html
   My bibliography  Save this book chapter

A Singularity in mRNA Virus, Virology, and Vaccinology

In: The Economics of Singularities of Science Elucidated with Buddhist Thoughts

Author

Listed:
  • S. Niggol Seo

    (Lamajel Ling)

Abstract

This chapter explores a singularity in virology—the science of viruses—and vaccinology—the science of vaccines. Relying on the recent experience of the COVID-19 pandemic from 2020 to 2023, it explains the SARS-CoV-2 virus, which is an mRNA virus, and the mRNA vaccines. The SARS-CoV-2 virus has killed 7 million people worldwide and infected 800 million people by the end of 2023. The mRNA vaccine is a novel vaccine in which only genetic instructions are contained, unlike the traditional Pasteur vaccine which is a weakened virus. About 6–7 billion doses of the two mRNA vaccines, the Pfizer’s Comirnaty and the Moderna’s Spikevax, were administered during the pandemic. It is remarkable that there has been continuing disputes over the origin of the virus. Although the virology is a natural progression of microbiological and biological science, a singularity risk may arise when the origin of a super virus cannot be discovered. The mechanism of such may involve subsequent wars and distrust among nations. From the standpoint of a singularity risk, it is important to make the virology research transparent to the public and it is vital to locate the origin of the virus as early as possible once a virus is identified.

Suggested Citation

  • S. Niggol Seo, 2024. "A Singularity in mRNA Virus, Virology, and Vaccinology," Springer Books, in: The Economics of Singularities of Science Elucidated with Buddhist Thoughts, chapter 0, pages 117-138, Springer.
    • Handle: RePEc:spr:sprchp:978-3-031-69118-8_6
    DOI: 10.1007/978-3-031-69118-8_6
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-031-69118-8_6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.